Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation

Article English OPEN
Bijland, S.; Mancini, S.J.; Salt, I.P.;
  • Publisher: Portland Press Ltd.
  • Subject: QH345 | RM

AMPK (AMP-activated protein kinase) is a key regulator of cellular and whole-body energy balance. AMPK phosphorylates and regulates many proteins concerned with nutrient metabolism, largely acting to suppress anabolic ATP-consuming pathways while stimulating catabolic A... View more
  • References (150)
    150 references, page 1 of 15

    19 Hawley, S. A., Pan, D. A., Mustard, K. J., Ross, L., Bain, J., Edelman, A. M., Frenguelli, B. G. and Hardie, D. G. (2005) Calmodulin-dependent protein kinase kinase β is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2, 9-19

    20 Woods, A., Dickerson, K., Heath, R., Hong, S. P., Momcilovic, M., Johnstone, S. R., Carlson, M. and Carling, D. (2005) Ca2+/calmodulin-dependent protein kinase kinase β acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2, 21-33

    21 Lin, Y. Y., Kiihl, S., Suhail, Y., Liu, S. Y., Chou, Y. H., Kuang, Z., Lu, J. Y., Khor, C. N., Lin, C. L. and Bader, J. S. (2012) Functional dissection of lysine deacetylases reveals that HDAC1 and p300 regulate AMPK. Nature 482, 251-255

    22 Zmijewski, J.W., Banerjee, S., Bae, H., Friggeri, A., Lazarowski, E.R. and Abraham, E. (2010) Exposure to hydrogen peroxide induces oxidation and activation of AMPactivated protein kinase. J. Biol. Chem. 285, 33154-33164.

    23 Zhang, B. B., Zhou, G. and Li, C. (2009) AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab. 9, 407-416

    24 Fryer, L.G., Parbu-Patel, A. and Carling, D. (2002) The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 277, 25226-25232

    25 Boyle, J.G., Salt, I.P. and McKay, G.A. (2010) Metformin action on AMP-activated protein kinase: a translational research approach to understanding a potential new therapeutic target. Diabet. Med. 27, 1097-1106

    26 Foretz, M., Hebrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F. and Viollet, B. (2010) Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J. Clin. Invest. 120, 2355-2369

    27 Guigas, B., Bertrand, L., Taleux, N., Foretz, M., Wiernsperger, N., Vertommen, D., Andreelli, F., Viollet, B. and Hue, L. (2006) 5-Aminoimidazole-4-carboxamide-1-betaD-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMPactivated protein kinase-independent effect on glucokinase translocation. Diabetes 55, 865-874

    28 Hawley, S.A., Fullerton, M.D., Ross, F.A., Schertzer, J.D., Chevtzoff, C., Walker, K.J., Peggie, M.W., Zibrova, D., Green, K.A., Mustard, K.J., Kemp, B.E., Sakamoto, K., Steinberg, G.R. and Hardie, D.G. (2012) The ancient drug salicylate directly activates AMP-activated protein kinase.Science 336, 918-922

  • Similar Research Results (3)
  • Metrics
Share - Bookmark